Gerresheimer has been commissioned by a well-known customer to produce plastic containers in which the active ingredient dexamethasone is to be filled. According to a study, the active ingredient can reduce the mortality of people who are seriously ill with Covid 19. Only recently, the medical journal and other media reported that the World Health Organization (WHO) had called for an increase in the production of the active ingredient dexamethasone.
"Thanks to globally standardized processes and technologies, we are able to produce flexibly, locally and sustainably. This also includes optimizing procurement and transport routes for our customers," says Jens Friis, Vice President Europe & Latin America at Primary Plastic Packaging, responsible for sales.
"For the packaging of dexamethasone, we supply 100ml drug cans with closures. "He explains that already in December 2019 the first mould was successfully transferred to the production site in Vaerloese, Denmark, in order to be able to supply local European markets in an optimal way."
As a specialist for pharmaceutical primary packaging, Gerresheimer for the packaging of the active ingredient. Even at the beginning of the corona pandemic, the company responded flexibly to its customers' requests for containers for filling hand disinfectants. At Gerresheimer the factors of procurement security, supply chain management and clearly defined throughput times are decisive key factors for high customer satisfaction in the service of people's health.
Image: This is the plastic can DB39 from Gerresheimer in which the dexamethasone tablets for the treatment of seriously ill Covid 19 patients are filled.
Consumers are placing great importance on sustainable products, specifically on sustainable packaging solutions that can be disposed of in an environmentally friendly way. A pioneer in the quest for greater sustainability, Gerresheimer offers an extensive standard range of plastic packaging and devises customized solutions made from PET, R-PET, and BIO-PET plastics.
Glass production begins with engineering the mould. The more accurately the moulds are designed and made, the greater the quality of the bottle. A perfect and even distribution of glass is the key to success when it comes to ensuring the robustness and sustainability of these highly sensitive products. Gerresheimer employs innovative simulation software for this purpose.
Gerresheimer is driving sustainable cosmetic glass packaging by using more post-consumer recycled glass
As a leading producer of glass packaging for cosmetic products, Gerresheimer is committed to driving sustainability in the sector. Gerresheimer has been successfully producing glass with a high proportion of post-consumer recycled (PCR) material for over 10 years in Momignies, Belgium.
"People buy scent with their eyes,” says Bernd Stauch, Senior Director Sales Cosmetics at Gerresheimer. Gerresheimer’s new high-performance Decoration Centers at Momignies in Belgium and Tettau in Germany employ the latest technology such as UV printing, to ensure that perfume products look as good as they smell.
Gerresheimer’s factories in Tettau (Germany) and Momignies (Belgium) specialize in the industrial production of cosmetic glass and have been supplying notable customers in the cosmetics industry for decades. At both sites, newly created, high-performance “Decoration Centers” use modern techniques to customize sophisticated branded products for the cosmetics market.
Gerresheimer's Gx Elite vials help ensure patient safety
With its Gx Elite and Gx RTF vials, Gerresheimer presents two new type I vials made from borosilicate glass. The Gx Elite vials are the result of a careful product development process spanning several years. The highly shatter-resistant vials are extremely durable, free of cosmetic defects and can be customized for specialized customer requirements.
Gerresheimer is investing a mid-double-digit million Euro figure in the new plant in the North Macedonian capital of Skopje, an amount that is already included in the company’s medium-term investment plans. Construction is beginning in the first half of 2019, with completion scheduled for the first half of 2020. It is expected that start of production will take place in the second half of 2020.
Gerresheimer will use this year's Pharmapack held in Paris, Porte de Versailles, as a platform to unveil their latest ophthalmology and rhinology services at booth B62. The company has teamed up with select certified partners to add surface finishing of plastic dropper bottles to their irradiation services.
The Gerresheimer Group increased revenues at constant exchange rates by 8.8% in the third quarter of 2018, from EUR 335.0m in the prior-year quarter to EUR 364.4m. This includes EUR 3.5m from Sensile Medical, which was acquired in July 2018. On an organic basis—meaning adjusted for exchange rate effects and Sensile Medical—revenues went up by 7.8% relative to the prior-year quarter.
Gerresheimer's handy Duma Pocket tablet containers are well-known for being drugs containers that fit into any bag. Because they are oval, they don't take up much space. Another great feature is that it can't open itself when it's inside a bag. It’s irritating when this happens and the tablets become loose. This is also beneficial when sending the product to users in the mail.
Gerresheimer extends business model and increases growth forecast
Gerresheimer is acquiring Swiss technology company Sensile Medical AG and thus fundamentally extends its business model. The acquisition enables Gerresheimer to offer drug delivery platforms with digital and electronic capabilities for pharmaceutical and biopharmaceutical customers.
Cosmetics packaging – Gerresheimer provides persuasive evidence through the appeal of glass
Gerresheimer belongs to the leading worldwide suppliers of glass for cosmetics. The company offers its visitors on May 10 and 11 at Luxepack 2017 in New York and at Beautyworld Middle East on May 14 up to 17 in Dubai the latest highlights out of enchanting new glass containers.
Gerresheimer introduces metal-free syringes
Biopharmaceuticals demonstrate a series of special features. They are often highly viscous and in individual cases tend to interact with silicone oil or, for example, tungsten residue from syringe production. Gerresheimer therefore offers integrated thin-walled cannulas for the improved emptying capability of the syringe for these applications.
Gerresheimer presents the first US bottle produced in multilayer at CPhI 2016
Gerresheimer is presenting an extension of our new multilayer plastic container, Duma Twist-Off Protect, at CPhI. Now the popular Triveni Round family has been extended by a 60 ml container with the multilayer features for the US market.
Highest quality vials: Gerresheimer consistently implements its vial machine strategy
Gerresheimer has set up an investment program spanning several years to install state-of-the-art converting machines for vial manufacturing at all its plants. The latest-generation machines and global high standards will enable it to meet even more stringent future requirements of product quality.
Gerresheimer banks on photovoltaics in Kundli, India
Being the leading global partner for the pharmaceutical and healthcare industries, Gerresheimer is committed to sustainability and environmental protection. The majority of Triveni Polymers in Kundli (India) belongs to the Gerresheimer Group since 2012.
The Gerresheimer Group is one of the market leaders for plastic pharmaceutical packaging in Brazil. The three Brazilian production facilities in the Sao Paolo region collectively manufacture several hundreds of millions of plastic containers and closures for diverse health and well-being-related applications every year. In 2015, Gerresheimer modernized the clean rooms at its Brazilian plants to achieve sustainable improvements in production quality.
- Jo Webb
- Brand Launch
- Created 20 Jul 2020
- Modified 30 Jul 2020
- Hits 92